Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025)

Fennec Pharmaceuticals' Treasury Shares history spans 5 years, with the latest figure at $387000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 19.44% year-over-year to $387000.0, compared with a TTM value of $387000.0 through Dec 2025, up 19.44%, and an annual FY2025 reading of $387000.0, up 19.44% over the prior year.
  • Treasury Shares for Q4 2025 was $387000.0 at Fennec Pharmaceuticals, down from $419000.0 in the prior quarter.
  • The five-year high for Treasury Shares was $589000.0 in Q1 2025, with the low at $35000.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $249944.4, with a median of $239000.0 recorded in 2023.
  • Year-over-year, Treasury Shares soared 522.86% in 2023 and then crashed 77.53% in 2025.
  • Tracing FENC's Treasury Shares over 5 years: stood at $55000.0 in 2021, then tumbled by 36.36% to $35000.0 in 2022, then soared by 522.86% to $218000.0 in 2023, then soared by 48.62% to $324000.0 in 2024, then increased by 19.44% to $387000.0 in 2025.
  • Per Business Quant, the three most recent readings for FENC's Treasury Shares are $387000.0 (Q4 2025), $419000.0 (Q3 2025), and $100000.0 (Q2 2025).